Paper

Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer's disease model.

Published Sep 1, 2018 · DOI · M. Pinz, A. S. dos Reis, A. G. Vogt

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCTAnimal StudyRigorous Journal

Study Snapshot

4-PSQ protects against memory impairment and anxiety in an Alzheimer's disease mouse model, with anticholinesterase and antioxidant actions contributing to its pharmacological effect.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer's disease model.

References

Citations